Pan-cancer Landscape of Programmed Death Ligand-1 and Programmed Death Ligand-2 Structural Variations

Overview of attention for article published in JCO Precision Oncology, January 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
Above-average Attention Score compared to outputs of the same age and source (59th percentile)

Mentioned by

twitter: 18 X users

patent: 1 patent

Readers on

mendeley: 21 Mendeley

So far, Altmetric has seen 18 X posts from 18 X users, with an upper bound of 78,706 followers.

IMMUNOTHERAPY: structural variants targeting the PDL1 and PDL2 loci result in increased gene expression and identify tumours more likely to respond to PD1 inhibition. https://t.co/ekhQDLlZTz

RT @Adebola_serifat: https://t.co/rq1WNtOjbp Another publication thanks to the Roychowdhury lab, it was a delight working on this.

https://t.co/rq1WNtOjbp Another publication thanks to the Roychowdhury lab, it was a delight working on this.

RT @krthkynmrgsn: We are delighted to share our work on the growing evidence of PDL1 gene rearrangements as predictive biomarkers of immuno…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 14 additional X posts.